Search
Now showing items 1-5 of 5
Mass Spectrometry-based Diagnostics: The Upcoming Revolution in Disease Detection Has Already Arrived
(2003)
Interference by hemoglobin is clearly
labeled in the VITROS
®
Troponin I
assay’s “Instructions For Use” and
Package Insert. The hemoglobin con-centrations used and the differences
measured are stated under“Limita-tions ...
Use of Tandem Mass Spectrometry for Multianalyte Screening of Dried Blood Specimens from Newborns
(2003)
Background:Over the past decade laboratories that test
for metabolic disorders have introduced tandem mass
spectrometry (MS/MS), which is more sensitive, spe-cific, reliable, and comprehensive than traditional as-says, ...
Application of Tandemmass Spectrometry to Neonatal Screening for Inherited Disorders of Intermediary Metabolism.
(2002)
This review is intended to serve as a practical guide for geneticists to
current applications of tandem mass spectrometry to newborn screening. By making
dried-blood spot analysis more sensitive, specific, reliable, and ...
Neonatal Blood Carnitine Concentrations: Normative Data by Electrospray Tandem Mass Spectometry
(2003)
Despite a number of published reports, there is limited infor-mation about carnitine metabolism in the newborn. To establish
normative data, we analyzed whole-blood carnitine concentra-tions in 24,644 newborns at age 1.85 ...
Automated Tandem Mass Spectrometry for Mass Newborn Screening for Disorders in Fatty Acid, Organic Acid, and Amino Acid Metabolism.
(1999)
Automated Tandem Mass Spectrometry for Mass Newborn Screening for Disorders in Fatty Acid, Organic Acid, and Amino Acid Metabolism.